Lv3
276 积分 2025-03-14 加入
Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial
26天前
已完结
Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer
1个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
4个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
6个月前
已完结
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
7个月前
已完结
Essential oil from Tragopogon dubius selectively inhibits breast (MCF-7) and glioblastoma (LN-18) cancer cell proliferation; insights into antioxidant, genoprotective potential, and GCMS, GCGCTOFMS-based profiling
9个月前
已完结
Increased Oxygen Stimulation Promotes Chemoresistance and Phenotype Shifting through PLCB1 in Gliomas
11个月前
已完结
皖公网安备34019202002308
